| Financial Year |
March 31 2023 |
| Monetary Funds |
682,005,534.66 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
324,787,288.22 |
| Accounts Receivable |
267,028,470.22 |
| Advances to Suppliers |
16,646,515.23 |
| Other Receivables |
64,236,350.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
623,458,048.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,462,588.21 |
| Total Current Assets |
2,156,311,417.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
35,291,726.54 |
| Investment Properties |
-- |
| Fixed Assetes |
1,608,181,880.37 |
| Under-construction Projects |
158,103,012.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
4,310,090.05 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
358,030,750.99 |
| R&D expenses |
-- |
| Goodwill |
164,038,070.15 |
| Long-Term Deferred and Prepaid Expenses |
138,985,648.18 |
| Deferred Income Tax Assets |
232,008,542.34 |
| Other Non-Current Assets |
67,501,547.86 |
| Sub-Total of Non-Current Assets |
2,814,142,105.59 |
| Total Assets |
4,970,453,522.86 |
| Short-Term Loans |
624,716,252.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
151,462,764.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,849,130.69 |
| Taxes Payable |
54,861,769.92 |
| Interest Payable |
866,534.45 |
| Dividend Payable |
-- |
| Other payables |
139,745,339.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
170,415,189.55 |
| Other Current Liabilities |
11,400,094.49 |
| Sub-Total of Current Liabilities |
1,220,889,907.38 |
| Long-term Loans |
348,038,338.26 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
649,444.84 |
| Deferred Income Tax Liabilities |
35,622,443.18 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
517,714,134.19 |
| Total Liabilities |
1,738,604,041.57 |
| Paid-In Capital(Or Share Stock) |
791,927,400.00 |
| Capital Surplus |
733,836,676.92 |
| Surplus Reserve |
298,071,214.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,263,817,508.95 |
| Minority Stockholder's Interest |
143,207,809.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,088,641,671.79 |
| Owner's Equity（Stockholder's Equity） |
3,231,849,481.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,970,453,522.86 |
